Investment Rating - The report rates the industry as "Overweight," indicating a positive outlook for the sector compared to the overall market performance [4]. Core Insights - The recent passage of the "One, Big, Beautiful Bill" in the U.S. House of Representatives is expected to significantly impact the new energy sector, particularly electric vehicles and solar storage, with stricter requirements for "foreign restricted entities" [4]. - The electric vehicle market is projected to face short-term demand challenges due to the cancellation of a $7,500 subsidy by the end of 2025, while the domestic lithium battery industry maintains a comparative advantage [4]. - The report highlights that the new bill introduces a transition period of 1-2 years for compliance with the "foreign restricted entity" requirements, which may lead to a rush in installations in the short term [4]. Summary by Sections Electric Vehicles - The cancellation of the $7,500 subsidy by the end of 2025 is expected to negatively affect U.S. electric vehicle demand in the short term, but the impact on Chinese companies is limited due to their low export ratio to the U.S. [4]. - The report notes that the U.S. electric vehicle penetration rate is currently low at 9.8%, with projected sales of 1.56 million units in 2024 [4]. Solar Storage - The report discusses the gradual reduction of ITC and PTC subsidies, with the new bill implementing a phased reduction starting in 2029 [4]. - The ITC subsidy is set to decrease from 30% to 0% by 2032, while the PTC subsidy will also see significant reductions [4]. Investment Recommendations - The report suggests focusing on four main investment themes for 2025: 1. True Growth: Companies like CATL, EVE Energy, and LONGi Green Energy [4]. 2. Cycle Recovery: Companies such as Hunan Youneng and Fulin Precision [4]. 3. New Technologies: Firms like Xiamen Tungsten and Rongbai Technology [4]. 4. Supply-side Reform: Companies including Tongwei and GCL-Poly [4]. Valuation Table - A valuation table is provided for key companies in the power equipment sector, detailing their market capitalization, earnings per share (EPS) forecasts, and price-to-earnings (PE) ratios for 2025-2027 [5].

Company Overview - Shangtai Technology Co., Ltd. was established in 2008 and is headquartered in Wuqiao County, Shijiazhuang City, specializing in the R&D, integrated production, and sales of lithium-ion battery anode materials [1] - The company is listed on the Shenzhen Stock Exchange and is recognized as a leading high-tech enterprise in its industry [1] Recent Performance - Shangtai Technology has experienced a decline in stock price, with a cumulative drop of 8.15% over the last five trading days [1] - The company's performance in 2023 shows a year-to-date return of 3.17%, ranking 2023 out of 4574 in its category [2] Shareholder Activity - Dongfang Fund, under the management of Dongfang New Energy Mixed Fund, has increased its holdings in Shangtai Technology and is among the top ten shareholders [1] Fund Management - The fund manager for Dongfang New Energy Mixed Fund is Li Rui, who has extensive experience in equity investment and has been with Dongfang Fund since July 2011 [3][4] - Li Rui has managed various funds, including those focused on new energy and automotive industries, indicating a strategic focus on sectors aligned with Shangtai Technology's business [3][4]

2025.05. 26 【今日推荐】 俄大使馆遭无人机袭击 当地时间25日，俄罗斯驻瑞典外交使团称，一架携带颜料的无人机袭击了俄罗斯驻瑞典大使馆。据 悉，无人机在夜间向使馆主入口前的平台投掷了一个装有颜料的玻璃容器。 市场监管总局：我国平台经济监管政策体系进一步完善 市场监管总局价监竞争局有关负责同志就《网络交易平台收费行为合规指南（征求意见稿）》答记者 问：总体上看，《指南》的出台，标志着我国平台经济监管政策体系的进一步完善。《指南》以问题 为导向，针对纠治平台收费不透明、不合理等问题提出了具体要求。同时，还强调平台企业的自我规 范、自我监督，提高平台企业落实合规管理主体责任的主动性，推动形成政府监管与企业自律相结合 的治理格局。《指南》对保障平台内经营者知情权、选择权等合法权益作出明确规定，鼓励平台采取 多种措施降低经营者负担，提供让利或减免扶持，对平台内经营者有关收费问题的关切也要及时予以 反馈。未来，随着《指南》的落地实施，将有助于平台企业优化收费合规建设，推动行业健康发展， 构建平台和平台内经营者和谐共生的良好生态。 国乒4金收官！"双曼"组合夺冠！ 当地时间5月25日，2025年多哈世乒赛完成全部 ...

Group 1: Comac Medical Group Acquisition - Comac Medical Group, supported by EdgeCap Partners, announced the acquisition of ILIFE Consulting, a specialized CRO based in Paris, focusing on oncology, rare diseases, and complex early-stage biotech clinical trials [3] - The acquisition enhances Comac's presence in Western Europe, complementing its recent expansions in the UK, Germany, and the US [3] - ILIFE's CEO, Marina Iché, will continue to lead the company and become a significant shareholder, ensuring continuity in corporate culture and service [3] - The acquisition strengthens Comac's technical and service capabilities in early clinical trials, increasing its competitiveness in attracting emerging biotech clients [3] - The growing European biopharmaceutical innovation landscape positions Comac as a preferred clinical R&D outsourcing partner for small and medium-sized biotech companies [3] - EdgeCap Partners' strategy of building regional leaders through platform acquisitions in the CRO industry is noteworthy [3] Group 2: Kelun Pharmaceutical - Kelun Pharmaceutical has transitioned from traditional infusion business to innovative drugs and synthetic biology, with strong stock performance and high market expectations [2] - Despite a decline in revenue and profit in Q1 2025, the stock price continued to rise, indicating market confidence in its future [2] - The company faces challenges with its TROP2 ADC drug due to competition from Gilead's products and reliance on a single client for its innovative drug collaborations [4] Group 3: Shanghai Public Hospital Salary Reform - Shanghai's health commission announced a pilot program for annual salary reform in public hospitals, starting with Zhongshan Hospital and Ruijin Hospital [3] - The reform aims to optimize salary structures and may expand to cover doctors and other medical staff, shifting incentives towards long-term performance [3] - DRG and DIP reforms are expected to encourage medical institutions to focus on treatment quality rather than quantity, benefiting innovative and effective drugs [3] Group 4: Cigna and Novo Nordisk Agreement - Cigna's Evernorth has reached an agreement with Novo Nordisk and Eli Lilly to significantly reduce prices for GLP-1 weight loss drugs, benefiting employers and employees [4] - The agreement is expected to provide a 30-50% discount for employers, aligning with the US government's ongoing negotiations for Medicare discounts [4] - Employee out-of-pocket costs will be capped at $200/month, enhancing drug accessibility compared to direct purchase prices [4] Group 5: Domestic Electric Vehicle Sales - In April, the penetration rate of new energy vehicles exceeded 51.7%, with a notable increase in the share of A00 and A0 class small electric vehicles, indicating consumer sensitivity to price [5] - The mid-to-low-end electric vehicle market is expected to expand rapidly, benefiting battery material companies and midstream suppliers [5] - BYD maintained a leading market share of 32.9%, while Tesla's Model Y saw a significant sales decline of 30.7%, reflecting challenges in pricing and product cycles [5] - Midstream material companies are likely to benefit directly from the increase in sales volume as the market shifts towards cost-sensitive models [5][6]

①MSCI中国指数调整将生效；②5月PMI数据将公布；③华为将举行尊界S800发布会。 除MSCI中国指数以外，MSCI中国A股在岸指数的成分股名单也有所调整，增加成分股8只，包括翱捷科技-U、中国卫通、海思科、杭钢股份、艾力斯、百 利天恒、拓维信息、芯原股份。调整结果将于5月30日收盘后生效。 5月PMI数据将公布 5月31日，国家统计局将公布5月PMI数据。据国家统计局，4月份，制造业采购经理指数为49.0%，比上月下降1.5个百分点；非制造业商务活动指数和综合 PMI产出指数分别为50.4%和50.2%，继续保持在扩张区间。 国家统计局服务业调查中心高级统计师赵庆河指出，总体看，综合PMI产出指数自2023年1月以来始终位于临界点以上，我国经济总体产出持续扩张，长期 向好的基本面没有改变。受外部环境急剧变化等因素影响，4月份制造业采购经理指数有所回落，但高技术制造业等相关行业继续保持扩张，以内销为主的 制造业企业生产经营总体稳定。 【重磅新闻】 MSCI中国指数调整将生效 日前，明晟公司（MSCI）公布了5月份指数审议结果。在本次调整中，MSCI中国指数新纳入芯原股份、百利天恒、惠泰医疗、光线传媒、海思 ...

Core Viewpoint - The article discusses the United States' efforts to strengthen its position in the battery industry, particularly in the anode material sector, to reduce reliance on Chinese companies [1][2]. Group 1: U.S. Government and Corporate Initiatives - The U.S. government is intervening by identifying subsidies for Chinese battery components, particularly active anode materials, as a precursor to imposing anti-subsidy tariffs [1]. - American company GDI is raising an additional $11.5 million to expand its silicon-based anode production, bringing its total Series A funding to over $20 million [1]. - GDI is constructing its first MWh-level silicon-based anode production project in Germany, set to commence production in 2025 [1]. Group 2: GDI's Technological Advancements - GDI has developed a 100% silicon anode that has shown a capacity exceeding 3200 mAh/g in third-party tests, with over 30% higher energy density compared to graphite anodes [1][2]. - In thermal runaway tests, GDI's silicon anode integrated into a Navitas 3.5Ah pouch battery demonstrated an energy density exceeding 250 Wh/kg, with no fire or smoke after being punctured for 10 hours [2]. - GDI plans to collaborate with AGC to utilize improved glass coating equipment for roll-to-roll production, aiming for GWh production by 2028 for electric vehicles [2]. Group 3: Market Dynamics and Challenges - The theoretical capacity of silicon-based anodes can reach 4200 mAh/g, significantly higher than graphite, aligning with the development needs of solid-state batteries and other new technologies [2]. - Despite the potential, the production process for silicon-based anodes faces technical bottlenecks and high costs, leading to slower adoption in the power sector compared to consumer markets [3]. - Current production capacity is predominantly concentrated in Chinese companies, making it challenging for overseas firms to catch up in the silicon-based anode sector [3].

证券代码：001301 证券简称：尚太科技 公告编号：2025-066 石家庄尚太科技股份有限公司 关于公司2023年限制性股票激励计划首次授予限制性股票 第一个限售期解除限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要提示： 年限制性股票激励计划首次授予限制性股票第一个解除限售期解除限售条件已 经成就，符合解除限售条件的激励对象共计68名，解除限售的限制性股票数量为 本公司于2025年3月13日分别召开了第二届董事会第十七次会议和第二届监 事会第十五次会议，审议通过了《关于2023年限制性股票激励计划首次授予部分 第一个解除限售期条件成就的议案》。根据《上市公司股权激励管理办法》、 《2023 年限制性股票激励计划（草案）》（以下简称"《激励计划》"）、《2023年限 制性股票激励计划实施考核管理办法》（以下简称"《考核管理办法》"）等的 规定，公司2023年限制性股票激励计划（以下简称"本激励计划"）首次授予限 制性股票第一个限售期解除限售条件已经成就。根据公司2023年第三次临时股东 大会的授权，公司为68名符合解除限售 ...

石家庄尚太科技股份有限公司 关于公司2023年限制性股票激励计划首次授予限制性股票 第一个限售期解除限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：001301 证券简称：尚太科技 公告编号：2025-066 重要提示： 1、石家庄尚太科技股份有限公司（以下简称"公司"或"本公司"）2023 年限制性股票激励计划首次授予限制性股票第一个解除限售期解除限售条件已 经成就，符合解除限售条件的激励对象共计68名，解除限售的限制性股票数量为 354,000股，占公司当前总股本的0.1357%。 2、本次解除限售的限制性股票解除限售上市流通日为2025年5月28日。 本公司于2025年3月13日分别召开了第二届董事会第十七次会议和第二届监 事会第十五次会议，审议通过了《关于2023年限制性股票激励计划首次授予部分 第一个解除限售期条件成就的议案》。根据《上市公司股权激励管理办法》、《2023 年限制性股票激励计划（草案）》（以下简称"《激励计划》"）、《2023年限 制性股票激励计划实施考核管理办法》（以下简称"《考核管理办法》" ...

Investment Rating - The report maintains an investment rating of "Outperform the Market" for the lithium battery industry [1][4]. Core Insights - The lithium battery index has outperformed the CSI 300 index since the beginning of 2025, with a rise of 4.75%, surpassing the CSI 300 index by 2.95 percentage points as of May 16, 2025 [4][11]. - The revenue for the lithium battery sector in 2024 was 2.25 trillion yuan, a slight increase of 0.07% year-on-year, while net profit was 110.14 billion yuan, down 22.02% year-on-year [7][21]. - In Q1 2025, the sector's revenue reached 527.3 billion yuan, up 18.12% year-on-year, with 68.87% of companies reporting positive growth [7][18]. - The demand for new energy vehicles (NEVs) in China continues to grow, with sales reaching 4.299 million units in the first four months of 2025, a year-on-year increase of 46.27% [7][52]. - The report highlights a differentiated pricing trend in the lithium supply chain, with lithium carbonate prices down 15.51% year-to-date, while cobalt prices have increased by 43.11% due to external policy influences [7][21]. Summary by Sections Market Performance - The lithium battery sector has shown a significant recovery in performance, with the index rising 4.75% in 2025, outperforming the CSI 300 index [11][12]. - The performance of specific stocks within the sector has varied, with some stocks experiencing substantial gains while others have seen declines [12][13]. Sector Revenue and Profitability - The lithium battery sector's revenue has shown a compound annual growth rate (CAGR) of 21.80% from 2018 to 2024, with a peak revenue of 2.25 trillion yuan in 2024 [17][21]. - The net profit for the sector has fluctuated, with a significant drop in 2024, but a recovery is expected in 2025 with a projected positive growth in net profit [21][23]. New Energy Vehicle Sales - Global NEV sales reached 4.11 million units in the first quarter of 2025, reflecting a year-on-year growth of 27.93% [49][52]. - China's NEV sales have also surged, with a total of 4.299 million units sold in the first four months of 2025, marking a 46.27% increase year-on-year [51][52]. Raw Material Pricing - The report notes a significant price differentiation in the lithium supply chain, with lithium carbonate prices decreasing while cobalt prices have increased due to policy changes [7][21]. Investment Evaluation and Focus Areas - The report suggests maintaining an "Outperform the Market" rating based on the sector's growth prospects and valuation levels, recommending focus on three main investment lines [4][7].

石家庄尚太科技股份有限公司 关于 2024 年年度权益分派实施公告 证券代码：001301 证券简称：尚太科技 公告编号：2025-065 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 已回购股份数量为 1,106,100 股，根据《中华人民共和国公司法》《上市公司股 份回购规则》等法律、行政法规的规定，该部分已回购股份不享有利润分派的权 利。因此，公司实施本次权益分派的股本基数为公司现有总股本剔除已回购股份 后的 259,731,250 股，向全体股东每 10 股派发现金红利 8.00 元（含税），合计 派发红利 207,785,000 元，本年度不转增不送股。 的每 10 股现金红利（含税）=实际现金分红总额/公司现有总股本=207,785,000 元 /260,837,350 股*10 股=7.966075 元，公司 2024 年年度权益分派实施后除权除息 参考价=权益分派股权登记日收盘价-按公司总股本折算的每股现金红利（即 石家庄尚太科技股份有限公司（以下简称"公司"或"本公司"）2024 年年度权 益分派方案已获 2025 年 4 月 ...